Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
US9822107B2 · kind B2 · utility
0Cited by
20References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2014 |
| Grant date | Nov 21, 2017 |
| Priority date | — |
| Expiry date | Dec 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein ring R1, R2, R3, R4, ring B, and the subscript r are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.